Your browser doesn't support javascript.
loading
Hemophagocytic syndrome triggered by donor-transmitted toxoplasmosis as a complication in same-donor recipients of renal transplantation: Case report and review of the literature.
Valdés Francí, Elena; Perez Flores, Isabel; Candel, Francisco Javier; Moreno de la Higuera, María Angeles; Romero, Natividad Calvo; Rodríguez Cubillo, Beatriz; Lucena Valverde, Rafael; Sánchez Fructuoso, Ana Isabel.
Afiliação
  • Valdés Francí E; Nephrology Department, Clínico San Carlos University Hospital, Madrid, Spain.
  • Perez Flores I; Nephrology Department, Clínico San Carlos University Hospital, Madrid, Spain.
  • Candel FJ; Department of Clinical Microbiology and Infectious Diseases, Clínico San Carlos University Hospital, Madrid, Spain.
  • Moreno de la Higuera MA; Nephrology Department, Clínico San Carlos University Hospital, Madrid, Spain.
  • Romero NC; Nephrology Department, Clínico San Carlos University Hospital, Madrid, Spain.
  • Rodríguez Cubillo B; Nephrology Department, Clínico San Carlos University Hospital, Madrid, Spain.
  • Lucena Valverde R; Nephrology Department, Clínico San Carlos University Hospital, Madrid, Spain.
  • Sánchez Fructuoso AI; Nephrology Department, Clínico San Carlos University Hospital, Madrid, Spain.
Transpl Infect Dis ; 23(6): e13732, 2021 Dec.
Article em En | MEDLINE | ID: mdl-34533259
ABSTRACT

BACKGROUND:

Hemophagocytic syndrome (HPS) is an infrequent complication of transplantation caused by an inflammatory response with a benign proliferation of macrophages and defective lytic capability of T lymphocytes and NK cells that can lead to multiorgan failure. Transplant patients are particularly exposed as a result of the increased risk of both infections and malignancies derived from immunosuppressive drugs. There is no consensus for therapy or immunosuppressionmortality is high. We report a case and present a review of all cases of HPS occurring in solid organ transplant recipients.  CASE REPORT We report two cases of infection by Toxoplasma gondii transmitted by the kidney allograft. One of the recipients was seronegative before transplantation and developed disseminated primary toxoplasmosis. An immune reaction compatible with an HPS ensued. Both were treated with Trimethoprim/sulfamethoxazole, immunosuppression was tapered, and after a 2-week period a complete response was obtained.

CONCLUSION:

HPS presents therapeutic challenges in the context of transplantation. If HPS is suspected, the search of a very likely underlying infection should be central to the management.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Toxoplasma / Toxoplasmose / Transplante de Rim / Linfo-Histiocitose Hemofagocítica Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Toxoplasma / Toxoplasmose / Transplante de Rim / Linfo-Histiocitose Hemofagocítica Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article